Back to Search Start Over

Molecular Dynamics Simulations and Experimental Results Provide Insight into Clinical Performance Differences between Sandimmune® and Neoral® Lipid-Based Formulations.

Authors :
Warren DB
Haque S
McInerney MP
Corbett KM
Kastrati E
Ford L
Williams HD
Jannin V
Benameur H
Porter CJH
Chalmers DK
Pouton CW
Source :
Pharmaceutical research [Pharm Res] 2021 Sep; Vol. 38 (9), pp. 1531-1547. Date of Electronic Publication: 2021 Sep 24.
Publication Year :
2021

Abstract

Objective: Molecular dynamics (MD) simulations provide an in silico method to study the structure of lipid-based formulations (LBFs) and the incorporation of poorly water-soluble drugs within such formulations. In order to validate the ability of MD to effectively model the properties of LBFs, this work investigates the well-known cyclosporine A formulations, Sandimmune® and Neoral®. Sandimmune® exhibits poor dispersibility and its absorption from the gastrointestinal tract is enhanced when administered after food, whereas Neoral® disperses comparatively well and shows no food effect.<br />Methods: MD simulations were performed of both LBFs to investigate the differences observed in fasted and fed conditions. These conditions were also tested using an in vitro experimental model of dispersion and digestion.<br />Results: These MD simulations were able to show that the food effect observed for Sandimmune® can be explained by large changes in drug solubilization on addition of bile. In contrast, Neoral® is well dispersed in water or in simulated fasted conditions, and this dispersion is relatively unchanged on moving to fed conditions. These differences were confirmed using dispersion and digestion in vitro experimental model.<br />Conclusions: The current data suggests that MD simulations are a potential method to model the fate of LBFs in the gastrointestinal tract, predict their dispersion and digestion, investigate behaviour of APIs within the formulations, and provide insights into the clinical performance of LBFs.<br /> (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)

Details

Language :
English
ISSN :
1573-904X
Volume :
38
Issue :
9
Database :
MEDLINE
Journal :
Pharmaceutical research
Publication Type :
Academic Journal
Accession number :
34561814
Full Text :
https://doi.org/10.1007/s11095-021-03099-5